Bank of New York Mellon
MDLN

Bank of New York Mellon’s Medline Inc MDLN Stock Holding History

Bank of New York Mellon’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.4M Buy
1,025,107
+319,837
+45% +$12.9M 0.01% 1204
2026
Q1 		$31.4M Buy
705,270
+656,135
+1,335% +$29M 0.01% 1278
2025
Q4 		$2.06M Buy
+49,135
New +$2.07M ﹤0.01% 2813

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon's MDLN Position: Q2 2026 in Review

Bank of New York Mellon increased its Medline Inc (MDLN) stake by 45% in Q2 2026, buying an estimated $12.9M and bringing the position to 1,025,107 shares worth $40.4M. The position accounts for 0.01% of the portfolio, ranked #1204.

Bank of New York Mellon first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Bank of New York Mellon held 1,025,107 shares of Medline Inc worth $40.4M as of Q2 2026.
  • Bank of New York Mellon bought 319,837 Medline Inc shares in Q2 2026, an estimated $12.9M.
  • Medline Inc made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1204 holding.
  • Bank of New York Mellon first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.